|
USP42 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.938500E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.481800E-01 |
| Normal-vs-Stage2 |
1.665600E-01 |
| Normal-vs-Stage3 |
7.74810000000459E-05 |
| Normal-vs-Stage4 |
8.042600E-04 |
| Stage1-vs-Stage2 |
4.641800E-01 |
| Stage1-vs-Stage3 |
1.841360E-03 |
| Stage1-vs-Stage4 |
1.135660E-02 |
| Stage2-vs-Stage3 |
1.398190E-01 |
| Stage2-vs-Stage4 |
2.204800E-01 |
| Stage3-vs-Stage4 |
8.932800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.024400E-03 |
| Normal-vs-AfricanAmerican |
1.941960E-01 |
| Normal-vs-Asian |
6.075800E-01 |
| Caucasian-vs-AfricanAmerican |
6.535000E-01 |
| Caucasian-vs-Asian |
2.529800E-01 |
| AfricanAmerican-vs-Asian |
3.848400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.028900E-04 |
| Normal-vs-Female |
3.080400E-01 |
| Male-vs-Female |
1.262210E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.787600E-02 |
| Normal-vs-Age(41-60Yrs) |
1.838420E-02 |
| Normal-vs-Age(61-80Yrs) |
1.881540E-02 |
| Normal-vs-Age(81-100Yrs) |
6.274200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.045400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.672800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.471400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.355000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.971800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.585200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.822200E-01 |
| Normal-vs-Grade 2 |
3.786800E-01 |
| Normal-vs-Grade 3 |
8.25690000000323E-05 |
| Normal-vs-Grade 4 |
1.961620E-04 |
| Grade 1-vs-Grade 2 |
2.964800E-01 |
| Grade 1-vs-Grade 3 |
1.091190E-01 |
| Grade 1-vs-Grade 4 |
7.582100E-02 |
| Grade 2-vs-Grade 3 |
5.245500E-04 |
| Grade 2-vs-Grade 4 |
9.449800E-04 |
| Grade 3-vs-Grade 4 |
3.542600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
9.557000E-01 |
| Normal-vs-ccB subtype |
5.73799999999958E-05 |
| ccA subtype-vs-ccB subtype |
2.01179999999024E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.407870E-02 |
| Normal-vs-N1 |
1.976000E-01 |
| N0-vs-N1 |
5.123800E-01 |
|
|
